Boehringer Ingelheim announced layoffs in late November 2016, specifically on Thursday, December 1, 2016. The company confirmed plans to eliminate approximately 244 positions across the United States, with about 180 of those cuts occurring in Connecticut. This decision was part of a broader restructuring strategy, which included closing the small molecule discovery functions at their Ridgefield, Connecticut facility.
The layoffs were part of a series of reductions in 2016. Earlier that year, in June, Boehringer Ingelheim had announced the elimination of 724 jobs across the U.S., primarily affecting sales positions.
Therefore, while there were significant layoffs announced around that time, there is no specific information indicating that Boehringer Ingelheim conducted layoffs on the Tuesday after Thanksgiving in 2016.